- Sunday, November 9, 2025
- India +91 7982732466
- U.S +1 217 953 4020
- Info@Shingetsuresearch.com
Global Infectious Disease Rapid Diagnostics Testing Market
- April 8, 2020
- ID: SR/HC-45
- Format:Pdf
- Pages:220
Global Infectious Disease Rapid Diagnostics Testing Market- By Product (Over-the-Counter [OTC] Rapid Test Product and Professional Rapid Test Product), By Application (Infectious Disease, Cardiology, Oncology, Pregnancy & Fertility, Toxicology, Glucose Monitoring, and Others), and End User (Hospital & Clinic, Diagnostic Laboratory, Home Care, and Others), and By Region (North America, Europe, Asia Pacific, South America, and Middle East, & Africa)- Global forecast from 2022-2030.
Global Infectious Disease Rapid Diagnostics Testing Market Overview:
The global Infectious Disease Rapid Diagnostics Testing market is estimated to reach USD 35.2 billion by 2030, growing at a CAGR of 5.6% during the forecast period of 2022-2030. It was valued at USD 22.9 billion in 2022.
The infectious disease diagnosis market has always been the largest market segment in the IVD industry, and the contagious disease diagnosis technology has been continuously developing. The emerging pathogens, viruses, and outbreak of infections caused infectious diseases. Evolving lifestyles has increased diseases like diabetes, cardiovascular diseases, which raises the high burden of infectious diseases in developing countries.
Global Infectious Disease Rapid Diagnostics Testing Market Insights
With more and more global outbreaks of rare diseases, the need for more accurate screening is becoming extremely necessary. These are stimulating the development of the infectious disease rapid diagnosis testing market.
POCT testing is the fastest-growing subfield in the IVD industry, and it has unusually high applicability in first aid, critical illness rescue, and other scenarios that require a rapid diagnosis. POCT refers to the early testing performed in the frontline of clinical treatment, commonly known as “bedside testing,” which can eliminate the complicated processing procedures for specimens in laboratory testing and quickly obtain test results.
Moreover, the rapid diagnosis testing market characterized by its proper individualization and convenience and consists of unlimited business opportunities. Such as Existing STD disease detection kits mainly include a modified new Treponema pallidum antibody rapid detection kit and an HIV- syphilis multiple quick detection kit. The ease of use, detection accuracy, and pricing of the test kits will become critical competitive factors for the product.
Furthermore, new technologies such as genetic testing, companion diagnostics, liquid biopsy, NIPT, and nucleic acid blood tests, etc. are fueling the market demand for the rapid diagnosis technology market. These technologies are striving to cover the forefront of in-vitro diagnostic technology applications to analyze future trends and growth points of the industry. Therefore, it also attracts clinical laboratory physicians and in-vitro diagnostic companies in fueling the market demand for the global Infectious disease rapid diagnostics testing market.
Growth Driver
Increasing chronic diseases
The Infectious disease rapid diagnostics testing market is rising mainly due to emerging cases of infectious diseases, cardiovascular diseases, and cancer. Moreover, the evolving pathogens and emerging new diseases require the urgent need for the diagnosis of such contagious diseases is rising the demand for rapid diagnostic testing.
Development of home kits
The advancement in technology has improved the techniques and design of the medical instruments, which has fueled the market demand for the disease rapid diagnostics testing market. The propelling need for an in-expensive test kit, as well as the accuracy rate of diagnosis, is spurring the market share of the rapid diagnosis test home kits.
By Product Segmental Analysis
Based on product, the global infectious disease rapid diagnostics testing market bifurcated into Over the Counter [OTC] Rapid Test Product and Professional Rapid Test Product. The Over the Counter [OTC] Rapid Test Product segment accounted for the largest share and anticipated to grow during the forecast period from 2022-2030. The OTC rapid test product helps in providing accurate results within minutes. Therefore, it helps the patient to take further treatment without any delay.
By Application Segmental Analysis
Based on the Application, the global infectious disease rapid diagnostics testing market classified into Infectious Disease, Cardiology, Oncology, Pregnancy & Fertility, Toxicology, Glucose Monitoring, and Others. Infectious diseases have the largest market share in the global infectious disease rapid diagnostics testing market. The increasing cases of contagious diseases have propelled the market for a quick and accurate test. The technology advancement has fueled the market demand for non-invasive devices for home care aid. Therefore, pregnancy kits, rapid tests for HIV test kits, and other quick test devices have emerged in the market. Moreover, the availability, cost-effectiveness, and accessibility are also fueling the market demand for the global infectious disease rapid diagnostics testing market.
By End-user Segmental Analysis
Based on the End-user, the global infectious disease rapid diagnostics testing segmented into Hospital & Clinic, Diagnostic Laboratory, Home Care, and Others. The home care segment has emerged the market share of the global infectious disease rapid diagnostics testing market and expected to dominate in the forecast period as well. It is mainly owing to the flexibility, ease of use, availability, affordable and accurate, and rapid result from the devices has improved the adoption of the new diagnosis testing kits. Therefore, the home care segment will propel the market demand for the global infectious disease fast diagnostics testing market.
Region Segmental Analysis
Based on geography, the global infectious disease rapid diagnostics testing market segmented into North America, Asia Pacific, Europe, South America, and Middle East & Africa. North America expected to hold the largest share of the global infectious disease rapid diagnostics testing market. The Asia Pacific projected to grow at the propelling rate during the forecast period. Factors such as increasing adoption of test kits for early diagnosis and government investment in R&D due to rising prevalence of infectious diseases and emerging advance technology in the healthcare industry have fueled the demand for infectious disease rapid diagnostics testing in Asia Pacific region.
Competitor Analysis
Companies such as Abbott Laboratories, Becton, Dickinson and Company, Biomérieux SA, Bio-Rad Laboratories, Danaher Corporation, Diasorin, Luminex, Meridian Bioscience, Quidel, Roche Diagnostics, Siemens AG, Thermo Fisher Scientific, and others are key players in the global infectious disease rapid diagnostics testing market.
Key Stakeholders
- Market research and consulting firms
- Industry associations
- Global infectious disease rapid diagnostics testing manufacturing companies
- Research organizations and consulting companies’ infectious disease rapid diagnostics testing
- Regulatory bodies
Recent Development
- In February 2022, Mylab Discovery Solutions released CoviSwift, a point-of-care (POC) RT-PCR testing system for small labs, in-hospital labs, airports, and residents.
The objective of the Research
- Market modeling starts with identifying a target market where historical data exists. A Market can include prediction problems, economic factors, analyzing customer behavior, and identifying new patterns from past events, which helps our client to have deep dive into the market.
- Product analysis involves steps such as examining product features, costs, availability, quality, and other aspects. Product analysis is conducted to understand potential buyers and measure competition in the market.
- Market Trend and Economic Factors Analysis helps in assessing potential changes to an economy’s inflation rate, taxes, interest rates, exchange rates, trading regulations, and excise duties that can or have a major effect on the target market.
- Market Segmental Analysis defines in-depth scenario of the target market by the process of grouping consumers into naturally existing created segments of consumers who share similar product preferences or characteristics
- The geographical mapping approach helps our clients to understand national or international markets because different consumers in different regions have different needs wants, and cultural characteristics that can be specifically targeted.
Market Modelling
By Product
- Over-the-Counter (OTC) Rapid Test Product
- Professional Rapid Test Product
By Application
- Infectious Disease
- Cardiology
- Oncology
- Pregnancy & Fertility
- Toxicology
- Glucose Monitoring
- Others
By End-use
- Hospital & Clinic
- Diagnostic Laboratory
- Home Care
- Others
By Region
- Europe
- North America
- Asia Pacific
- South America
- Middle East & Africa
More Related Reports:
Europe Spare Parts Logistics in Night Market
Live Cell Encapsulation Market
Industrial Marking and Labelling System Market
Global Passenger Information System Market
Global Fluid Warmer Device Market
Report Content
- Research Strategic Development
1.1. Market Modelling
1.2. Product Analysis
1.3. Market Trend and Economic Factors Analysis
1.4. Market Segmental Analysis
1.5. Geographical Mapping
1.6. Country Wise Segregation
- Research Methodology
2.1. Identification of Target Market
2.2. Data Acquisition
2.3. Refining of Data/ Data Transformations
2.4. Data Validation through Primary Techniques
2.5. Exploratory Data Analysis
2.6. Graphical Techniques/Analysis
2.7. Quantitative Techniques/Analysis
2.8. Visual Result/Presentation
- Executive Summary
- Market Insights
4.1. Supply Chain Analysis
4.2. Economic Factor Analysis
4.2.1. Drivers
4.2.2. Trends
4.2.3. Opportunities
4.2.4. Challenges
4.3. Technological Landscape
4.4. Competitors & Product Analysis
4.5. Regulatory Framework
4.6. Company market share analysis, 2022
4.7. Porter’s Five forces analysis
4.8. Price point analysis
4.9. New Investment Analysis
4.10. PESTEL Analysis
- Global Infectious Disease Rapid Diagnosis Testing Market Overview
5.1. Market Size & Forecast,2017-2030
5.1.1. Demand
5.1.1.1. By Value (USD Billion)
5.2. Market Share & Forecast, 2017-2030
5.2.1. By Product
5.2.1.1. Over-the-Counter (OTC) Rapid Test Product
5.2.1.2. Professional Rapid Test Product
5.2.2. By Application
5.2.2.1. Infectious Disease
5.2.2.2. Cardiology
5.2.2.3. Oncology
5.2.2.4. Pregnancy & Fertility
5.2.2.5. Toxicology
5.2.2.6. Glucose Monitoring
5.2.2.7. Others
5.2.3. By End-Use
5.2.3.1. Hospital & Clinic
5.2.3.2. Diagnostic Laboratory
5.2.3.3. Home Care
5.2.3.4. Others
5.2.4. By Region
5.2.4.1. North America
5.2.4.2. Europe
5.2.4.3. Asia-Pacific
5.2.4.4. South America
5.2.4.5. The Middle East & Africa
- North America Infectious Disease Rapid Diagnosis Testing Market Overview
6.1. North America Infectious Disease Rapid Diagnosis Testing Market Size & Forecast,2017-2030
6.1.1. Demand
6.1.1.1. By Value (USD Billion)
6.2. Market Share & Forecast, 2017-2030
6.2.1. By Product
6.2.1.1. Over-the-Counter (OTC) Rapid Test Product
6.2.1.2. Professional Rapid Test Product
6.2.2. By Application
6.2.2.1. Infectious Disease
6.2.2.2. Cardiology
6.2.2.3. Oncology
6.2.2.4. Pregnancy & Fertility
6.2.2.5. Toxicology
6.2.2.6. Glucose Monitoring
6.2.2.7. Others
6.2.3. By End-Use
6.2.3.1. Hospital & Clinic
6.2.3.2. Diagnostic Laboratory
6.2.3.3. Home Care
6.2.3.4. Others
6.2.4. By Country
6.2.4.1. US
6.2.4.2. Canada
6.2.4.3. Mexico
6.2.5. Company Market Share (Top 3-5)
6.2.6. Economic Impact Study on North America Infectious Disease Rapid Diagnosis Testing Market
- Europe Infectious Disease Rapid Diagnosis Testing Market Overview
7.1. Europe Infectious Disease Rapid Diagnosis Testing Market Size & Forecast,2017-2030
7.1.1. Demand
7.1.1.1. By Value (USD Billion)
7.2. Market Share & Forecast, 2017-2030
7.2.1. By Product
7.2.1.1. Over-the-Counter (OTC) Rapid Test Product
7.2.1.2. Professional Rapid Test Product
7.2.2. By Application
7.2.2.1. Infectious Disease
7.2.2.2. Cardiology
7.2.2.3. Oncology
7.2.2.4. Pregnancy & Fertility
7.2.2.5. Toxicology
7.2.2.6. Glucose Monitoring
7.2.2.7. Others
7.2.3. By End-Use
7.2.3.1. Hospital & Clinic
7.2.3.2. Diagnostic Laboratory
7.2.3.3. Home Care
7.2.3.4. Others
7.2.4. By Country
7.2.4.1. Germany
7.2.4.2. UK
7.2.4.3. France
7.2.4.4. Italy
7.2.4.5. Rest of Europe
7.2.5. Company Market Share (Top 3-5)
7.2.6. Economic Impact Study on Europe Infectious Disease Rapid Diagnosis Testing Market
- Asia-Pacific Infectious Disease Rapid Diagnosis Testing Market Overview
8.1. Asia-Pacific Infectious Disease Rapid Diagnosis Testing Market Size & Forecast,2017-2030
8.1.1. Demand
8.1.1.1. By Value (USD Billion)
8.2. Market Share & Forecast, 2017-2030
8.2.1. By Product
8.2.1.1. Over-the-Counter (OTC) Rapid Test Product
8.2.1.2. Professional Rapid Test Product
8.2.2. By Application
8.2.2.1. Infectious Disease
8.2.2.2. Cardiology
8.2.2.3. Oncology
8.2.2.4. Pregnancy & Fertility
8.2.2.5. Toxicology
8.2.2.6. Glucose Monitoring
8.2.2.7. Others
8.2.3. By End-Use
8.2.3.1. Hospital & Clinic
8.2.3.2. Diagnostic Laboratory
8.2.3.3. Home Care
8.2.3.4. Others
8.2.4. By Country
8.2.4.1. India
8.2.4.2. Japan
8.2.4.3. Australia
8.2.4.4. Rest of Asia Pacific
8.2.5. Company Market Share (Top 3-5)
8.2.6. Economic Impact Study on Asia Pacific Infectious Disease Rapid Diagnosis Testing Market
- South America Infectious Disease Rapid Diagnosis Testing Market Overview
9.1. South America Infectious Disease Rapid Diagnosis Testing Market Size & Forecast,2017-2030
9.1.1. Demand
9.1.1.1. By Value (USD Billion)
9.2. Market Share & Forecast, 2017-2030
9.2.1. By Product
9.2.1.1. Over-the-Counter (OTC) Rapid Test Product
9.2.1.2. Professional Rapid Test Product
9.2.2. By Application
9.2.2.1. Infectious Disease
9.2.2.2. Cardiology
9.2.2.3. Oncology
9.2.2.4. Pregnancy & Fertility
9.2.2.5. Toxicology
9.2.2.6. Glucose Monitoring
9.2.2.7. Others
9.2.3. By End-Use
9.2.3.1. Hospital & Clinic
9.2.3.2. Diagnostic Laboratory
9.2.3.3. Home Care
9.2.3.4. Others
9.2.4. By Country
9.2.4.1. Brazil
9.2.4.2. Argentina
9.2.4.3. Rest of South America
9.2.5. Company Market Share (Top 3-5)
9.2.6. Economic Impact Study on South America Infectious Disease Rapid Diagnosis Testing Market
- The Middle East & Africa Infectious Disease Rapid Diagnosis Testing Market Overview
10.1. The Middle East & Africa Infectious Disease Rapid Diagnosis Testing Market Size & Forecast,2017-2030
10.1.1. Demand
10.1.1.1. By Value (USD Billion)
10.2. Market Share & Forecast, 2017-2030
10.2.1. By Product
10.2.1.1. Over-the-Counter (OTC) Rapid Test Product
10.2.1.2. Professional Rapid Test Product
10.2.2. By Application
10.2.2.1. Infectious Disease
10.2.2.2. Cardiology
10.2.2.3. Oncology
10.2.2.4. Pregnancy & Fertility
10.2.2.5. Toxicology
10.2.2.6. Glucose Monitoring
10.2.2.7. Others
10.2.3. By End-Use
10.2.3.1. Hospital & Clinic
10.2.3.2. Diagnostic Laboratory
10.2.3.3. Home Care
10.2.3.4. Others
10.2.4. By Country
10.2.4.1. Saudi Arabia
10.2.4.2. UAE
10.2.4.3. South Africa
10.2.4.4. Rest of the Middle East & Africa
10.2.5. Company Market Share (Top 3-5)
10.2.6. Economic Impact Study on Middle East & Africa Infectious Disease Rapid Diagnosis Testing Market
- Competitor Analysis
11.1. Company Description
11.2. Financial Analysis
11.3. Key Products
11.4. Key Management Personnel
11.5. Contact Address
11.6. SWOT Analysis
11.7. Company Profile
11.7.1. Abbott Laboratories
11.7.2. Becton, Dickinson and Company
11.7.3. Biomérieux SA
11.7.4. Bio-Rad Laboratories
11.7.5. Danaher Corporation
11.7.6. Diasorin
11.7.7. Luminex
11.7.8. Meridian Bioscience
11.7.9. Quidel
11.7.10. Roche Diagnostics
11.7.11. Siemens AG
11.7.12. Other Prominent Players
Frequently Asked Questions (FAQ)
The global Infectious Disease Rapid Diagnostics Testing market is estimated to reach USD 35.2 billion by 2030, growing at a CAGR of 5.6% during the forecast period of 2022-2030. It was valued at USD 22.9 billion in 2022.
New technologies such as genetic testing, companion diagnostics, liquid biopsy, NIPT, and nucleic acid blood tests, etc. are fueling the market demand for the rapid diagnosis technology market.
Companies such as Abbott Laboratories, Becton, Dickinson and Company, Biomérieux SA, Bio-Rad Laboratories, Danaher Corporation, Diasorin, Luminex, Meridian Bioscience, Quidel, Roche Diagnostics, Siemens AG, Thermo Fisher Scientific, and others are key players in the global infectious disease rapid diagnostics testing market.
Infectious diseases have the largest market share in the global infectious disease rapid diagnostics testing market.
